The Perrigo Company (Nasdaq: PRGO; TASE) has initiated a recall of certain store brand Acetaminophen 500 mg tablets. These Store Brand Acetaminophen Tablets are known to contain raw material (metal shavings) purchased from a third party supplier. These Store Brand Acetaminophen Tablets are sold for pain relief and to reduce fever.

John Hendrickson of Perrigo Consumer Healthcare recently said, “Our quality control systems noted trace amounts of metal particulate in a very small number of these caplet products…we are taking this measure to maintain the highest possible product quality standards for our retail customers…”

Perrigo has been telling its customers (retail stores and distributors) about this recall that affects 383 batches. They have also outlined steps the company will take to facilitate product replacement. Questions about this product recall should be directed to Perrigo’s Consumer Affairs Department. Consumer can call 1-877-546-0454 for more information.

Related Health News:

1. CVS Caremark Extends Google Health Partnership Customers can now securely download their prescription history from cvs.com to their Google Health Account WOONSOCKET, R.I., April 6 /PRNewswire/ — CVS Caremark today announced...
2. Mylan Announces Clarinex Settlement Agreement PITTSBURGH, April 8 /PRNewswire-FirstCall/ — Mylan Inc. (NASDAQ:MYL) today announced the settlement of all patent litigation relating to Desloratadine Tablets, 5 mg, the generic version...
3. Nu Skin Child Hunger Relief Effort Surpasses 150 Million Meals Nourish the Children(R) Promotes Sustained Food Donations PROVO, Utah, April 14 /PRNewswire-FirstCall/ — Nu Skin Enterprises (NYSE: NUS) today announced more than 150 million meals...
4. Federal Tobacco Tax Increase a Good Reason to Quit Smoking State offering free resources to help people kick the habit OLYMPIA, Wash., March 31 /PRNewswire-USNewswire/ — A new federal tobacco tax that takes effect April...
5. BioMarin to Present at Cowen and Company Health Care Conference NOVATO, Calif., March 2 /PRNewswire-FirstCall/ — BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company...